The goal of the Fred Hutchinson Cancer Research Center is to study and find cures for cancer and infectious diseases. Since it's opening in 1975, the Fred Hutchinson Cancer Research Center has pioneered many lifesaving cancer research breakthroughs and is still the only comprehensive cancer center in Oregon and Washington.
Last year, the BioResearch Product Faire™ Event at Fred Hutchinson Cancer Research attracted 157 attendees. Of these attendees, 46 were purchasing agents, professors and post docs, and 21 were lab managers. These attendees came from 9 different research buildings and 16 on-campus departments that study a wide variety of cancers and diseases.
Diseases studied at the Fred Hutchinson Cancer Research Center Include:
|Barrett's Esophagus||Multiple Myeloma|
|Brain Tumors||Multiple Sclerosis|
|Breast Cancer||Myelodysplastic Syndrome|
|Cervical Cancer||Opportunistic Infections|
|Colorectal (Colon) Cancer||Oral Cancer|
|Crohn's Disease||Ovarian Cancer|
|Cystic Fibrosis||Pancreatic Cancer|
|Esophageal Cancer||Prostate Cancer|
|Kaposi Sarcoma||Sickle Cell Disease|
|Leukemia||Skin Cancer (Melanoma)|
|Liver Cancer||Wilms Tumor|
LEARN MORE ABOUT THE SEATTLE RESEARCH MARKETPLACE:
The Fred Hutchinson Cancer Research Center is well funded by grants, awards and donations from organizations like the National Institutes of Health (NIH) and National Science Foundation (NSF), as well as from private donors. In the 2014 fiscal year, the center received a total of $227 million in funding from the NIH and its associated organizations. The organizations that awarded the most to the Fred Hutchinson Cancer Research Center were:
- National Cancer Institute - $95.5 million
- National Institute of Allergy and Infectious Disease - $86.7 million
- National Heart, Lung, and Blood Institute - $13.9 million
- National Institute of General Medical Sciences - $11.6 million
Below are additional key funding stats for the center:
- Annual research budget close to $400 million.
- The Fred Hutchinson Cancer Research Center, Memorial Sloan Kettering Cancer Center and Seattle Children's Research Institute have formed a new biotech company called Juno Therapeutics and is being launched with $120 million.
- The Fred Hutchinson Cancer Research Center received a donation of $20 million from Mike Bezos to support development of novel cancer immunotherapies.
- Uncovering colon cancer’s genetic roots is the focus of a new $13 million, four-year, National Cancer Institute-funded project at Fred Hutchinson Cancer Research Center.
(Photo Courtesy of Wikimedia)
The upcoming BioResearch Product Faire™ Event at the Fred Hutchinson Cancer Research Center on August 12, 2015 is a prime opportunity to see the newest laboratory technologies available and to network in the Northwest Life Science Community. It is a chance for lab supply companies to meet face-to-face with researchers on campus in a fun and professional environment.
Lab supply companies can learn more about participating in this event by visiting the button below:
Researchers at the Fred Hutchinson Cancer Research Center can learn more about attending the event, and pre-register for the event by visiting the button below: